288 related articles for article (PubMed ID: 26494142)
1. Next-generation sequencing and empowering personalised cancer medicine.
McDermott U
Drug Discov Today; 2015 Dec; 20(12):1470-5. PubMed ID: 26494142
[TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing, cancer and molecular diagnostics: an interview with Elaine Mardis.
Mardis E; Raison C
Expert Rev Mol Diagn; 2015 Apr; 15(4):449-50. PubMed ID: 25795041
[TBL] [Abstract][Full Text] [Related]
3. High-throughput sequencing technologies.
Reuter JA; Spacek DV; Snyder MP
Mol Cell; 2015 May; 58(4):586-97. PubMed ID: 26000844
[TBL] [Abstract][Full Text] [Related]
4. An Overview of DNA Analytical Methods.
Arboleda VA; Xian RR
Methods Mol Biol; 2019; 1897():385-402. PubMed ID: 30539459
[TBL] [Abstract][Full Text] [Related]
5. The rise of the genome and personalised medicine.
Brittain HK; Scott R; Thomas E
Clin Med (Lond); 2017 Dec; 17(6):545-551. PubMed ID: 29196356
[TBL] [Abstract][Full Text] [Related]
6. [The new challenge in oncology: Next-generation sequencing and its application in precision medicine].
Calabria I; Pedrola L; Berlanga P; Aparisi MJ; Sánchez-Izquierdo D; Cañete A; Cervera J; Millán JM; Castel V
An Pediatr (Barc); 2016 Nov; 85(5):273.e1-273.e7. PubMed ID: 27349697
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
Sheikine Y; Kuo FC; Lindeman NI
J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627
[TBL] [Abstract][Full Text] [Related]
8. Precision medicine for cancer with next-generation functional diagnostics.
Friedman AA; Letai A; Fisher DE; Flaherty KT
Nat Rev Cancer; 2015 Dec; 15(12):747-56. PubMed ID: 26536825
[TBL] [Abstract][Full Text] [Related]
9. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
10. Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.
Hyman DM; Solit DB; Arcila ME; Cheng DT; Sabbatini P; Baselga J; Berger MF; Ladanyi M
Drug Discov Today; 2015 Dec; 20(12):1422-8. PubMed ID: 26320725
[TBL] [Abstract][Full Text] [Related]
11. Clinical Applications of Next-Generation Sequencing.
Rebollar-Vega RG; Arriaga-Canon C; de la Rosa-Velázquez IA
Rev Invest Clin; 2018; 70(4):153-157. PubMed ID: 30067721
[TBL] [Abstract][Full Text] [Related]
12. Microarray and next-generation sequencing to analyse gastric cancer.
Dang Y; Wang YC; Huang QJ
Asian Pac J Cancer Prev; 2014; 15(19):8033-9. PubMed ID: 25338980
[TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing: implications in personalized medicine and pharmacogenomics.
Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N
Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891
[TBL] [Abstract][Full Text] [Related]
14. (Cyto)pathology and sequencing: Next (or last) generation?
Di Lorito A; Schmitt FC
Diagn Cytopathol; 2012 May; 40(5):459-61. PubMed ID: 21538954
[No Abstract] [Full Text] [Related]
15. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
Mack SC; Northcott PA
J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
[TBL] [Abstract][Full Text] [Related]
16. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
17. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
[TBL] [Abstract][Full Text] [Related]
18. Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.
Worst BC; van Tilburg CM; Balasubramanian GP; Fiesel P; Witt R; Freitag A; Boudalil M; Previti C; Wolf S; Schmidt S; Chotewutmontri S; Bewerunge-Hudler M; Schick M; Schlesner M; Hutter B; Taylor L; Borst T; Sutter C; Bartram CR; Milde T; Pfaff E; Kulozik AE; von Stackelberg A; Meisel R; Borkhardt A; Reinhardt D; Klusmann JH; Fleischhack G; Tippelt S; Dirksen U; Jürgens H; Kramm CM; von Bueren AO; Westermann F; Fischer M; Burkhardt B; Wößmann W; Nathrath M; Bielack SS; Frühwald MC; Fulda S; Klingebiel T; Koscielniak E; Schwab M; Tremmel R; Driever PH; Schulte JH; Brors B; von Deimling A; Lichter P; Eggert A; Capper D; Pfister SM; Jones DT; Witt O
Eur J Cancer; 2016 Sep; 65():91-101. PubMed ID: 27479119
[TBL] [Abstract][Full Text] [Related]
19. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
Syn NL; Yong WP; Goh BC; Lee SC
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
[TBL] [Abstract][Full Text] [Related]
20. Advancements in Next-Generation Sequencing.
Levy SE; Myers RM
Annu Rev Genomics Hum Genet; 2016 Aug; 17():95-115. PubMed ID: 27362342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
